Glenmark’s Ryaltris Close To Entry In Major Eastern Europe Market
Indian Firm Has Launched Already In Ukraine, Australia And South Africa
Ryaltris is under review with the US FDA, as well as regulators across Europe, Canada and Brazil. • Source: Shutterstock 
